Searched for
RANBAXY
NCLAT quashes Ligare Aviation's insolvency; loan from Religare Enterprises round-tripping of moneyThe National Company Law Appellate Tribunal has cancelled insolvency proceedings against Ligare Aviation. The tribunal found the National C...- After 50 hearings, court reserves judgement in Daiichi-Fortis caseThe Delhi High Court has reserved its judgment in a significant arbitration case. Japanese drug maker Daiichi Sankyo is seeking to enforce ...
- Fortis liability case: Delhi HC says blame can't be shifted to third partyAmid ongoing legal disputes, the Delhi High Court is probing Fortis Healthcare's oversight concerning the sale of shares belonging to the S...
- Jacqueline Fernandez withdraws plea to turn approver in money laundering caseActor Jacqueline Fernandez has withdrawn her plea to become an approver in the Sukesh Chandrashekar money laundering case. The Enforcement ...
- ED opposes Jacqueline Fernandez's approver plea in Rs 200 crore laundering caseThe Enforcement Directorate has opposed actor Jacqueline Fernandez's request to become an approver in a Rs 200 crore money laundering case....
- Sun Pharma-Organon deal: How a $12-billion merger will reshape India's pharma landscapeSun Pharma is set to nearly double its revenue to $12 billion with the acquisition of Organon, creating a global pharmaceutical giant. The ...
- Sun Pharma to acquire Organon for $11.75 billion in India’s biggest pharma dealSun Pharma, led by Dilip Shanghvi, has agreed to acquire US-based Organon in an all-cash deal worth $11.75 billion, marking the largest acq...
- Sun's strong gravity helps India Inc's pullSun Pharma has expanded its horizons by acquiring Organon, a notable New Jersey pharmaceutical firm. This strategic acquisition fortifies S...
- Sun Pharma: How a small Kolkata trader became a global buyout artistSun Pharma, led by Dilip Shanghvi, is poised for its largest overseas acquisition, a $12.5 billion deal for Organon & Co. This move continu...
- ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...
- Alkem Labs CEO Vikas Gupta may exit companyAlkem Labs, a leading Indian drug maker, is set for a top management change. Vikas Gupta, the CEO for nearly three years, is expected to de...
- Sun Pharma-Ranbaxy deal: Daichi Sankyo failed to harness the complexities of a strong generic business, says Malvinder SinghThe Sun-Ranbaxy combined entity will unlock the true potential of the Gurgaon based company, says former Ranbaxy owner Malvinder Singh.
- Sun Pharma to buy Ranbaxy in $3.2 bn deal: HighlightsSun Pharmaceutical Industries said that it will buy generic drug maker Ranbaxy Laboratories, has hit regulatory snags in its key US market ...
- Ranbaxy Q3 top-line seen up 33% at Rs 2698 croreRanbaxy is expected to report a 33 per cent jump in its net sales for the quarter ended September 30 to Rs 2698 crore.
- Ranbaxy launches generic version of Evoxac in US marketRanbaxy has launched generic cevimeline hydrochloride capsules, used in treating Sjogren's syndrome, in the US market.
- Ranbaxy opens new manufacturing facility in Morocco; eyes $1 bn drug marketRanbaxy has opened a new production facility in Morocco, a move which would help the drug maker access the African nation's $1 billion phar...
- Ranbaxy laboratories may hand over Latin American operations to Daiichi SankyoRanbaxy may hand over its L American mkting operations to Daiichi Sankyo, a move could be a precursor to the Indian drugmaker's exit from s...
- Daiichi to use Ranbaxy network to sell products in SingaporeRanbaxy and Daiichi Sankyo had signed a three-year plan to exploit synergies in operations to enhance their generic as well as branded busi...
- Ranbaxy transfers R&D unit to Daiichi SankyoRanbaxy Laboratories has transferred its research division for new drugs to Japan’s Daiichi Sankyo turning Ranbaxy into a pure generic drug...
- Daiichi's own man to head Ranbaxy qualityJapan's Daiichi Sankyo has named an executive with more than 25 years of experience to oversee the quality and manufacturing standards in R...
Load More
